324 related articles for article (PubMed ID: 15817334)
21. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
Pötter R; Gnant M; Kwasny W; Tausch C; Handl-Zeller L; Pakisch B; Taucher S; Hammer J; Luschin-Ebengreuth G; Schmid M; Sedlmayer F; Stierer M; Reiner G; Kapp K; Hofbauer F; Rottenfusser A; Pöstlberger S; Haider K; Draxler W; Jakesz R;
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):334-40. PubMed ID: 17363187
[TBL] [Abstract][Full Text] [Related]
22. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
23. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
[TBL] [Abstract][Full Text] [Related]
24. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
26. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
Cutuli B; Lemanski C; Le Blanc-Onfroy M; de Lafontan B; Cohen-Solal-Le-Nir C; Fondrinier E; Mignotte H; Giard S; Charra-Brunaud C; Auvray H; Gonzague-Casabianca L; Quétin P; Fay R
Cancer Radiother; 2013 Jun; 17(3):196-201. PubMed ID: 23538041
[TBL] [Abstract][Full Text] [Related]
27. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
28. The role of radiation therapy after local excision of invasive and noninvasive breast cancer.
Marks LB; Prosnitz LR
Surg Oncol Clin N Am; 1997 Apr; 6(2):359-79. PubMed ID: 9115501
[TBL] [Abstract][Full Text] [Related]
29. Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features.
McHaffie DR; Patel RR; Adkison JB; Das RK; Geye HM; Cannon GM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):46-51. PubMed ID: 20732760
[TBL] [Abstract][Full Text] [Related]
30. [Target volume and indications of radiotherapy in breast carcinoma].
Greiner RH
Praxis (Bern 1994); 1998 Apr; 87(17):595-601. PubMed ID: 9623327
[TBL] [Abstract][Full Text] [Related]
31. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
32. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
33. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
34. Conservative therapy of breast cancer in Queensland.
Burke MF; Allison R; Tripcony L
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):295-303. PubMed ID: 7836083
[TBL] [Abstract][Full Text] [Related]
35. A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer.
Lim M; Bellon JR; Gelman R; Silver B; Recht A; Schnitt SJ; Harris JR
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1149-54. PubMed ID: 16750330
[TBL] [Abstract][Full Text] [Related]
36. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
Jiveliouk I; Corn B; Inbar M; Merimsky O
Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after breast conservation treatment with radiation in women with prior nonbreast malignancy and subsequent invasive breast carcinoma.
Nemani D; Vapiwala N; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1055-60. PubMed ID: 18929447
[TBL] [Abstract][Full Text] [Related]
38. Long-term clinical outcomes of whole-breast irradiation delivered in the prone position.
Stegman LD; Beal KP; Hunt MA; Fornier MN; McCormick B
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):73-81. PubMed ID: 17337131
[TBL] [Abstract][Full Text] [Related]
39. Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients.
Livi L; Paiar F; Meldolesi E; Talamonti C; Simontacchi G; Detti B; Salerno S; Bianchi S; Cardona G; Biti GP
Eur J Surg Oncol; 2005 Feb; 31(1):9-12. PubMed ID: 15642419
[TBL] [Abstract][Full Text] [Related]
40. [Predictive factors of local recurrence of in situ intraductal carcinoma. Apropos of 217 cases].
Abbes M; Lange AC; Daoudi K; Lallement M
Bull Cancer; 1997 Feb; 84(2):135-40. PubMed ID: 9180835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
